Skip to main content
. 2018 Apr 18;9:586. doi: 10.3389/fmicb.2018.00586

FIGURE 3.

FIGURE 3

(A) The antibacterial potential of ZnO-NR-DAS combination therapy against MRSA as ascertained by measuring zone of inhibition incurred. (B) Fluorescence microscopic images corresponding to live dead cell assay employing PI and Syto-9 dyes to ascertain anti-bacterial potential of ZnO-NRs against MRSA ATCC BAA-1708 cells. (C) Growth kinetics analysis of MRSA upon their treatment with ZnO-NR-DAS.